David Anderson Recognized as a Leading Investor in Healthcare for 2025

David Anderson Named a Top Healthcare Investor of 2025

In an exciting development for the healthcare investment community, David Anderson, a General Partner at Ampersand Capital Partners, has earned recognition as one of the Top Healthcare Investors of 2025 by GrowthCap. This announcement, made on May 1, 2025, highlights Anderson's influential role in the healthcare sector and underscores his firm's commitment to growth equity investments in life sciences and healthcare.

Ampersand Capital Partners, established in 1988, has significantly impacted the healthcare landscape through its focus on growth-oriented investments. With an impressive portfolio that combines both private equity and operating experience, the firm has continually sought opportunities to innovate patient care and improve healthcare outcomes globally.

Expressing his gratitude, David Anderson stated, "I have the privilege of working alongside visionary leaders and exceptional teams who are driving innovation and transforming patient care. Being named a GrowthCap Top Healthcare Investor is truly an honor, but this recognition is more a reflection of Ampersand's collective dedication to partnering with founders and entrepreneurs to advance healthcare outcomes around the world."

The selection process for this accolade involved a rigorous evaluation of candidates' track records, industry expertise, and ability to adapt within the continuously changing healthcare environment. Anderson stood out among a competitive field, which included investors with deep knowledge in areas such as healthcare software, medical technologies, and biotechnology. Additionally, the nominees were assessed on their strategic insights which enhance their portfolio companies.

Managing Partner Herb Hooper praised Anderson's skills, saying, "David's ability to identify transformative opportunities and work hand-in-hand with entrepreneurs to bring bold ideas to life is helping to shape the next generation of healthcare innovation. We are proud to see David's leadership and impact celebrated through this well-deserved recognition."

The nomination process was comprehensive, involving recommendations from executives within portfolio companies, fellow industry professionals, and other respected investors. GrowthCap carefully reviewed each nominee’s professional achievements and contributions, ensuring a fair and thorough selection. Anderson, alongside other awardees, will be honored for their significant advances in the field from March 11, 2024, to March 12, 2025.

For those interested in understanding more about the award, the full list of the recognized investors, and insights about the selection process are available on the GrowthCap website.

About Ampersand Capital Partners

Ampersand Capital Partners is a middle-market private equity firm with over $3 billion in assets under management, dedicated to investments that drive growth in the healthcare sector. With headquarters in Boston, Massachusetts, and an office in Amsterdam, Netherlands, Ampersand has a reputation for building leading companies across vital health-related sectors. The firm aims to facilitate value creation and long-term success by collaborating closely with management teams.

To find out more about Ampersand Capital Partners and their innovative approach to healthcare investing, visit their official website or follow them on LinkedIn.

For more news and updates, keep an eye on healthcare investment trends and strategies that shape the future of patient care.